HRI Portal – health • research • innovation

  • About Us
    • About Research Canada
    • Sponsors
    • Contact
  • Information on Health Research
    and Innovation in Canada
    • The Current State of Health Research
      and Innovation in Canada
    • Research and Innovation in Action
    • CanadaSpeaks! 2019
    • Patient Stories
    • What’s Being Said:
      Blog and News
  • Resources for
    Advocates
    • Advocacy Messages
    • Tips for Effective Advocacy
      • Quick Tips for Effective Advocacy
      • Meeting with Candidates: Policy Questions and Answers
      • Using Social Media for Advocacy
      • Maximizing Your Impact: Town Halls
    • About Your Candidates
    • Advocates’ Toolkit
  • Resources for
    Candidates
    • Information on Health Research and Innovation
    • Candidate Survey

What's Being Said

  1. Home
  2. › Information on Health Research and Innovation in Canada
  3. › What's Being Said
  4. › Clinical trials: the cornerstone of innovative treatments
Clinical trials: the cornerstone of innovative treatments

Clinical trials: the cornerstone of innovative treatments

October 8, 2019September 11, 2019

As a critical step towards bringing new medicines and vaccines safely to market, clinical trials provide Canadians with access to new, potentially life-saving medications and therapies. These trials have been proven to increase the speed at which Canadian healthcare professionals and hospitals adopt healthcare innovations.

The pharmaceutical industry’s investments in clinical trials not only help to discover new innovative treatments for patients, they also help to reduce the cost of healthcare in Canada. A study completed by The Institute for Health Economics (IHE) in Alberta – and published in the journal of PharmacoEconomics –  demonstrates that industry-sponsored clinical trials completed in Canada in 2016 offset $2.1 billion in costs to the Canadian healthcare system. The study examined 394 pharmaceutical clinical trials that were completed in more than 2,000 facilities across the country with more than 20,000 Canadian patients.

When a pharmaceutical company sponsors a clinical trial, it covers the cost of the drug, as well as fees for ethics reviews, management costs such as start-up costs for labs and pharmacies, and patient care costs such as screening, procedures, treatments of adverse events and imaging procedures.

Canadian patients deserve the opportunity and hope that comes with innovative treatments being made available to them through clinical trials. Collaboration and coordination of all Canadian stakeholders is imperative to make this happen.

Competitiveness in quality, timeliness, and costs comes into play when global companies decide in which country to undertake trials. As a country with world class infrastructure that produces high quality data, a commitment to high ethical standards and presence of the world’s top 10 pharmaceutical companies, Canada has a distinct advantage when it comes to clinical trials.

Innovative Medicines Canada is the national voice of Canada’s innovative pharmaceutical industry. We advocate for policies that enable the discovery, development and commercialization of innovative medicines and vaccines that improve the lives of all Canadians. We support our members’ commitment to being valued partners in the Canadian healthcare system.

Producing Great Outcomes for Patients Locally and Globally with Made-in-Canada TreatmentsGreen Party leading the way on commitments to science and research
  • Age Well
  • Shift Health
  • Pediatric Chairs of Canada | Directeurs de pédiatrie du Canada
  • Children’s Healthcare Canada | Santé des enfants Canada
  • CAMH
  • Lady Davis Institute
  • Bausch Health
  • CHÉOS: Centre for Health Evaluation & Outcome Sciences
  • Université Concordia University
  • Roche
  • Diabetes Canada
  • AstraZeneca
  • Innovative Medicines Canada - Médicaments novateurs Canada
  • McMaster University – Brighter World
  • Canadian Nurses Foundation
  • Consumer Health Products Canada
  • Merck
  • The Canadian Forum for Rare Disease Innovators (RAREi)
  • Johnson & Johnson Family of Companies in Canada
  • National Collaborating Centre for Methods and Tools

Contact Us

Tweets

  • 3 hours ago RT @raredisorders: CORD invites you to share your experience of accessing care and treatment and your recommendations for a rare drug progr…
  • 3 hours ago RT @SickKidsNews: Across Canada, @ChooseWiselyCA has advocated for reducing unnecessary test, treatments and procedures in health care. @Dr…
  • 3 hours ago RT @getgutsycanada: "@getgutsycanada has been doing an outstanding job putting on COVID19 Webinars, lead by some amazing clinic scientists…
  • 3 hours ago RT @TheNeuro_MNI: Ce webinaire gratuit aura lieu le 21 janvier de 12h à 13h et portera sur l'état de la #santémentale dans les communautés…

About Research Canada

Research Canada is a national, broad-based alliance dedicated to increasing investments in health research through collaborative advocacy. We believe health research is shared benefit, shared responsibility and an investment in Canada’s future. We engage government, academia, industry and non-profit sectors to build support for balanced and long-term health research funding – investments that strengthen Canada’s innovation system and lead to better health, sustainable health care, new commercialization opportunities, and skilled jobs for Canadians.

Research Canada: An Alliance for Health Discovery / Recherche Canada : Une alliance pour les découvertes en santé
Your Candidates, Your Health Your Candidates, Your Health
HRI Portal – health • research • innovation
  • Sponsors
  • Health Research
    and Innovation
  • Resources for
    Candidates
  • Resources for
    Advocates
  • What’s Being Said:
    Blog and News
  • Contact
Research Canada/Recherche Canada © 2019 | All Rights Reserved | Tous droits réservés.